Found: 11
Select item for more details and to access through your institution.
Using national data to describe characteristics and determine acceptance factors of pharmacists' interventions: a six-year longitudinal study.
- Published in:
- International Journal of Clinical Pharmacy, 2023, v. 45, n. 2, p. 430, doi. 10.1007/s11096-022-01526-0
- By:
- Publication type:
- Article
Comparison of seven comorbidity scores on four-month survival of lung cancer patients.
- Published in:
- BMC Medical Research Methodology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12874-023-01994-6
- By:
- Publication type:
- Article
Dalbavancin in clinical practice: a particular place for the elderly?
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 6, p. 977, doi. 10.1007/s10096-022-04427-2
- By:
- Publication type:
- Article
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 2, p. 427, doi. 10.1111/bcp.14398
- By:
- Publication type:
- Article
Pharmacokinetic herb‐drug interaction between ginger and crizotinib.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1892, doi. 10.1111/bcp.13862
- By:
- Publication type:
- Article
Integrating anatomo‐physiological changes and pharmacogenomics in anti‐infective therapy management: is it a major concern?
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 1, p. 263, doi. 10.1111/bcp.13785
- By:
- Publication type:
- Article
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10939-7
- By:
- Publication type:
- Article
Lung cancer, comorbidities, and medication: the infernal trio.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2023.1016976
- By:
- Publication type:
- Article
Restrictive allograft dysfunction after lung transplantation: is there a place for nintedanib?—a case report.
- Published in:
- Fundamental & Clinical Pharmacology, 2020, v. 34, n. 3, p. 408, doi. 10.1111/fcp.12522
- By:
- Publication type:
- Article